Insider · CIK 0001808098
David Michael Johnson
Files at AURA (Aura Biosciences, Inc.), ZNTL (Zentalis Pharmaceuticals, Inc.). First filing May 20, 2025, latest May 20, 2025.
David Michael Johnson files SEC Form 4 as director at AURA (Aura Biosciences, Inc.), and also at ZNTL (Zentalis Pharmaceuticals, Inc.). Since May 20, 2025, David Michael Johnson has reported 1 open-market buy worth $98k and 0 open-market sells worth $0, the latest filed on May 20, 2025.
A track record needs three past buys with six months of prices behind them; David Michael Johnson has 0, so none is measured yet.
The newest scored trade: bought $98k of AURA on May 16, 2025, filed May 20, 2025, scored 44 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AURA: Aura Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Aura Biosciences, Inc. | $98k 20,000 shares | +14% | +21% from low-49% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Common Stock | +57,100 | $0.00 | $0 | 307,521 | Jun 18, 2026 |
| Jun 11, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 194,167 | Jun 15, 2026 |
| Jun 11, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 15, 2026 |
| Jun 17, 2025 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +13,000 | $0.00 | $0 | 179,167 | Jun 18, 2025 |
| Jun 17, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Common Stock | +57,603 | $0.00 | $0 | 250,421 | Jun 18, 2025 |
| Jun 17, 2025 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,000 | $0.00 | $0 | 17,000 | Jun 18, 2025 |
| May 16, 2025 | AURA Aura Biosciences, Inc. | POpen-market purchase Common Stock | +20,000 | $4.90 | $98k | 166,167 | May 20, 2025 |
| May 16, 2025 | AURA Aura Biosciences, Inc. | POpen-market purchase Common Stock Warrants (right to buy)derivative | +5,000 | - | - | 5,000 | May 20, 2025 |
Questions about David Michael Johnson
Answered from the filings on this page, as of the latest one.
Is David Michael Johnson buying or selling?
Not in the last 12 months. David Michael Johnson's latest open-market trade on SEC Form 4 was bought $98k of AURA on May 16, 2025.
How did David Michael Johnson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Michael Johnson has 0.
Where does David Michael Johnson file Form 4?
David Michael Johnson has filed Form 4 at AURA (Aura Biosciences, Inc.); ZNTL (Zentalis Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.